Novo Nordisk, the current market leader with a 55.1% value share in GLP-1s, faces increasing pressure from Eli Lilly, which has been gaining market share since mid-2024
Chronic cases may require a full 12-week cycle and occasionally a second cycle after a break to reach the target endpoint
The recommendations suggest that the use of GLP-1 RAs is projected to be of high value in comparison to other classes of diabetes medications
Diabetes Care 25 , 16991703 (2002)
Code availability No new code was used in this study
For most people, losing 10 pounds takes approximately six to twelve weeks, depending on starting weight, the specific medication, dose escalation speed, and adherence to dietary changes